← FDA DRUG APPROVALS

FDA ANDA · ANDA087742

OXYCODONE AND ASPIRIN (HALF-STRENGTH)

Sponsor: ROXANE

APPLICATION
ANDA087742
TYPE
ANDA
ORIGINAL APPROVAL
1982-06-04
LATEST ACTION
1982-06-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

OXYCODONE AND ASPIRIN (HALF-STRENGTH)Discontinued
ASPIRIN 325MG, OXYCODONE HYDROCHLORIDE 2.25MG, OXYCODONE TEREPHTHALATE 0.19MG · TABLET · ORAL

Approval history

1982-06-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →